Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-048931
Filing Date
2023-02-24
Accepted
2023-02-24 17:03:08
Documents
7
Period of Report
2023-04-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A d417044dpre14a.htm PRE 14A 677180
2 GRAPHIC g417044dsp1a.jpg GRAPHIC 17858
3 GRAPHIC g417044g0224071627751.jpg GRAPHIC 3731
4 GRAPHIC g417044g0224071628329.jpg GRAPHIC 23121
5 GRAPHIC g417044g0224071628626.jpg GRAPHIC 19017
6 GRAPHIC g417044g15a28.jpg GRAPHIC 392686
7 GRAPHIC g417044g16a28.jpg GRAPHIC 209098
  Complete submission text file 0001193125-23-048931.txt   1595775
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34375 | Film No.: 23668499
SIC: 3841 Surgical & Medical Instruments & Apparatus